Introduction to Long-Acting Injectable Antipsychotics and Patient Selection

Introduction to Long-Acting Injectable Antipsychotics and Patient Selection is organized by American Association of Psychiatric Pharmacists (AAPP).

Activity Dates: 05/31/2023 - 05/15/2026

Session Summary:
This webinar reviews the signs, symptoms, and diagnostic criteria for serious mental illnesses; guideline recommendations for LAI antipsychotic use; the barriers, advantages, and disadvantages for the use of LAIs; and the role of the pharmacist in LAI administration in the pharmacy setting.

This is one of six modules in the Psychotropic LAI Training Program. Complete your complimentary registration now to access this module, 5 other ACPE approved modules, a LAI Pocket Guide, administration videos, and an Administrative Toolkit.

Learning Objectives:

• Describe the signs, symptoms, and diagnostic criteria for schizophrenia, bipolar disorder, and schizoaffective disorder.
• Identify advantages and disadvantages for the use of long-acting injectable (LAI) antipsychotics.
• Describe the role of the pharmacist in LAI antipsychotic administration in the pharmacy setting.